Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Advertisement
Articles by Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Advertisement
Latest Updated Articles
The Wait for RSV Vaccines ContinuesPublished: April 26th 2023 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Coming Full Circle: How Mike Brundage Built a Thriving Pharmacy in Rural Pennsylvania
2
FDA Approves First 1-Minute Self Test for HIV
3
Orforglipron Demonstrates Superior Glycemic Control for Type 2 Diabetes
4
Interactive Test Understanding Flublok® (Influenza Vaccine)
5
